HemaSphere (Aug 2023)
S139: INTERIM ANALYSIS OF A REGISTRATION ENABLING STUDY OF PIVEKIMAB SUNIRINE (PVEK, IMGN632) A CD123-TARGETING ANTIBODY-DRUG CONJUGATE, IN PATIENTS WITH BLASTIC PLASMACYTOID DENDRITIC CELL NEOPLASM (BPDCN)
- Naveen Pemmaraju,
- Giovanni Martinelli,
- Pau Montesinos,
- Luca Mazzarella,
- Daniel J. Deangelo,
- Harry Erba,
- Kendra Sweet,
- Roland Walter,
- Eric Deconinck,
- Ollivier Legrand,
- Eunice Wang,
- Ahmed Aribi,
- Matthew Ulrickson,
- Giovanni Marconi,
- Andrew Lane,
- Hagop Kantarjian,
- Callum Sloss,
- Kara Malcolm,
- Patrick Zweidler-Mckay,
- Naval Daver
Affiliations
- Naveen Pemmaraju
- 1 MD Anderson Cancer Center, Houston, United States
- Giovanni Martinelli
- 2 IRCCS Istituto Romagnolo per lo Studio dei Tumori “Dino Amadori” IRST S.r.l., Meldola, Italy
- Pau Montesinos
- 3 Hospital Universitario i Politècnico la Fe, Valencia, Spain
- Luca Mazzarella
- 4 European Institute of Oncology IRCCS, Milano, Italy
- Daniel J. Deangelo
- 5 Dana-Farber Cancer Institute, Boston, United States
- Harry Erba
- 6 Duke University, Durham, United States
- Kendra Sweet
- 7 Moffitt Cancer Center and Research Institute, Tampa, United States
- Roland Walter
- 8 Fred Hutchinson Cancer Center, Seattle, United States
- Eric Deconinck
- 9 Hematology, CHU Besançon-Hématologie, Besançon, France
- Ollivier Legrand
- 10 Hospital St. Antoine, Paris, France
- Eunice Wang
- 11 Roswell Park Comprehensive Cancer Center, Buffalo, United States
- Ahmed Aribi
- 12 City of Hope, Duarte, United States
- Matthew Ulrickson
- 13 Banner MD Anderson Cancer Center, Gilbert, United States
- Giovanni Marconi
- 2 IRCCS Istituto Romagnolo per lo Studio dei Tumori “Dino Amadori” IRST S.r.l., Meldola, Italy
- Andrew Lane
- 5 Dana-Farber Cancer Institute, Boston, United States
- Hagop Kantarjian
- 1 MD Anderson Cancer Center, Houston, United States
- Callum Sloss
- 14 ImmunoGen, Inc, Waltham, United States
- Kara Malcolm
- 14 ImmunoGen, Inc, Waltham, United States
- Patrick Zweidler-Mckay
- 14 ImmunoGen, Inc, Waltham, United States
- Naval Daver
- 1 MD Anderson Cancer Center, Houston, United States
- DOI
- https://doi.org/10.1097/01.HS9.0000967468.85099.f4
- Journal volume & issue
-
Vol. 7
p. e85099f4
Abstract
No abstracts available.